In the population with non-small cell lung cancer (NSCLC), the incidence of mesenchymal-epithelial transition factor exon 14 (METex14) skipping mutations is approximately 3%-4%. However, the prevalence of this mutation appears to be lower among patients with N... ...

请注册登录后继续浏览